Role of CGMS Usage in Predicting Risk for Hypoglycemia
NCT03481530
Diabetes Mellitus, Diabetes Mellitus, Type 2
Minneapolis, Minnesota, United States
View Trial DetailsNCT Number: NCT01176656
The purpose of this study is to assess the burden of hypoglycemia and identify unmet need related to the management of hypoglycemia among Type 2Diabetes Mellitus (T2DM) patients on OADs and/or insulin. This is an observational study which will identify patients with T2DM in an administrative claims database and will link claims data with results of patient and physician surveys concerning hypoglycemia.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: October 2009-October 2010
Time frame: October 2009-October 2010
Time frame: October 2009-October 2010
AstraZeneca
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03481530
Diabetes Mellitus, Diabetes Mellitus, Type 2
Minneapolis, Minnesota, United States
View Trial DetailsNCT06384118
Adherence Interventions, Behavior
Yangzhou, 未选择, China
View Trial DetailsNCT00641407
Diabetes Mellitus, Diabetes Mellitus, Type 2
Naples, Italy
View Trial DetailsNCT05933161
Diabetes Mellitus, Diabetes Mellitus, Type 2
Rochester, Minnesota, United States
View Trial Details